LD: tumour limited to one potential irradiation field | ED: not confined to one hemithorax, malignant pleural effusion or distant metastases | |
Median survival of all patients | 16–24 months | 6–12 months |
5-year survival of all patients | 14% | Rare |
Supportive care | 3 months | 1.5 months |
Single-agent chemotherapy | 6 months | 4 months |
Combined chemotherapy | 10–14 months | 7–11 months |
5-year survival | 2–8% | 0–1% |
Chemotherapy plus radiation | 12–16 months | 7–11 months |
5-year survival | 6–12% | 0–1% |
LD: limited disease; ED: extensive disease.